Article thumbnail

Differentially regulated splice variants and systems biology analysis of Kaposi's sarcoma-associated herpesvirus-infected lymphatic endothelial cells

By Ting-Yu Chang, Yu-Hsuan Wu, Cheng-Chung Cheng and Hsei-Wei Wang


Alternative RNA splicing greatly increases proteome diversity, and the possibility of studying genome-wide alternative splicing (AS) events becomes available with the advent of high-throughput genomics tools devoted to this issue. Kaposi's sarcoma associated herpesvirus (KSHV) is the etiological agent of KS, a tumor of lymphatic endothelial cell (LEC) lineage, but little is known about the AS variations induced by KSHV. We analyzed KSHV-controlled AS using high-density microarrays capable of detecting all exons in the human genome. Splicing variants and altered exon–intron usage in infected LEC were found, and these correlated with protein domain modification. The different 3′-UTR used in new transcripts also help isoforms to escape microRNA-mediated surveillance. Exome-level analysis further revealed information that cannot be disclosed using classical gene-level profiling: a significant exon usage difference existed between LEC and CD34+ precursor cells, and KSHV infection resulted in LEC-to-precursor, dedifferentiation-like exon level reprogramming. Our results demonstrate the application of exon arrays in systems biology research, and suggest the regulatory effects of AS in endothelial cells are far more complex than previously observed. This extra layer of molecular diversity helps to account for various aspects of endothelial biology, KSHV life cycle and disease pathogenesis that until now have been unexplored

Topics: Gene Regulation, Chromatin and Epigenetics
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1999). A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis.
  2. (2010). AltAnalyze and DomainGraph: analyzing and visualizing exon expression data.
  3. (2006). Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
  4. (2009). Alternative splicing in the differentiation of human embryonic stem cells into cardiac precursors.
  5. (2010). Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
  6. (2006). An RNA map predicting Nova-dependent splicing regulation.
  7. (2008). Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.
  8. (2010). Beta-catenin deficiency causes DiGeorge syndrome-like phenotypes through regulation of Tbx1.
  9. (2006). Cell context reveals a dual role for Maf in oncogenesis.
  10. (2004). Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers.
  11. (2004). Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data.
  12. (2004). Direct binding of the human homologue of the Drosophila disc large tumor suppressor gene to seven-pass transmembrane proteins, tumor endothelial marker 5 (TEM5), and a novel TEM5-like protein.
  13. (2011). Discovery of a viral NLR homolog that inhibits the inflammasome.
  14. (2007). Discovery of tissue-specific exons using comprehensive human exon microarrays.
  15. (2008). easyExon–a Java-based GUI tool for processing and visualization of Affymetrix exon array data.
  16. (2002). Efficient infection by a recombinant Kaposi’s sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.
  17. (2010). Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2–brief report.
  18. (2010). Epigenetic analysis of KSHV latent and lytic genomes.
  19. (2008). Fhl-1, a new key protein in pulmonary hypertension.
  20. (2008). Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2.
  21. (2010). GATA switches as developmental drivers.
  22. (2009). Gene networks and microRNAs implicated in aggressive prostate cancer.
  23. (2003). Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.
  24. (2002). Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays.
  25. (2010). Hematopoiesis and its disorders: a systems biology approach.
  26. (1999). Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis.
  27. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma.
  28. (2008). Identification of Spt5 target genes in zebrafish development reveals its dual activity in vivo.
  29. (2007). IGFBP2 as a brain tumor oncogene.
  30. (2006). Immortalization of primary endothelial cells by the K1 protein of Kaposi’s sarcoma-associated herpesvirus.
  31. (2009). Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma.
  32. (2007). Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells.
  33. (2004). Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
  34. (2003). Kaposi’s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.
  35. (2007). Kaposi’s sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.
  36. (2009). Kaposi’s sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells.
  37. (1998). Kaposi’s sarcoma. Coupling herpesvirus to angiogenesis.
  38. (2010). KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.
  39. (2010). KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.
  40. (2004). Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.
  41. (2005). MicroRNA biogenesis and cancer.
  42. (2006). MicroRNAs modulate the angiogenic properties of HUVECs.
  43. (2008). miRBase: tools for microRNA genomics.
  44. (2007). Network analysis of oncogenic Ras activation in cancer.
  45. (2005). Nova regulates brain-specific splicing to shape the synapse.
  46. (2005). Overlapping gene expression in fetal mouse intestine development and human colorectal cancer.
  47. (2010). Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.
  48. (2000). Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology.
  49. (2004). Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform.
  50. (2009). RNA-Seq: a revolutionary tool for transcriptomics.
  51. (2001). Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.
  52. (2005). Significant expression of IGFBP2 in breast cancer compared with benign lesions.
  53. (2007). Strategies that modulate inflammasomes: insights from host-pathogen interactions.
  54. (2000). The hallmarks of cancer.
  55. (2007). The insulin receptor is essential for virus-induced tumorigenesis of Kaposi’s sarcoma.
  56. (2010). The lytic transcriptome of Kaposi’s sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes.
  57. (2009). The M type K15 protein of Kaposi’s sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion.
  58. (2007). Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.
  59. (2008). Translational control: a new dimension in embryonic stem cell network analysis.
  60. (2009). Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.
  61. (2004). Use of the red fluorescent protein as a marker of Kaposi’s sarcoma-associated herpesvirus lytic gene expression.
  62. (2010). Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma.